Zhongyang Lin

Tumor immune microenvironment remodeling predicts response to checkpoint inhibitor therapy.

Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, yet the basis of variable patient responses remains unclear. We assemble a longitudinal single-cell RNA sequencing atlas of 441 samples from 241 patients across ten cancer entities to map treatment-associated remodeling of the tumor immune microenviro...